ISRCTN71917916已完成未知
The implementation of microarrays in cancer diagnosis (microarray prognostics in breast cancer)
etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI AVL) (The Netherlands)0 个研究点目标入组 750 人开始时间: 2007年2月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 750
研究概览
简要总结
2007 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18042430 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19955335 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36126477/ 10 year follow up (added 27/09/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Female patients
- •2. With primary operable unifocal breast cancer
- •3. Without clinical signs of lymph node involvement or distant metastasis
- •4. Younger than 55 years of age
排除标准
- •A prior history of any malignancy with the exception of cervical dysplasia and basal cell carcinoma.
研究者
相似试验
已完成
不适用
RATIO: Rational Approach To Immuno-OncologyMetastatic MelanomaNCT02700971AHS Cancer Control Alberta35
已完成
不适用
Microarray Analysis in breast cancer to Taylor Adjuvant Drugs Or Regimens, a randomized phase III studyBreastCancerBreast cancerISRCTN61893718etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI AVL)664
撤回
4 期
A Post-Marketing Clinical Study of Apligraf for Venous Leg UlcersVaricose UlcerNCT00648674Organogenesis
已完成
不适用
Microarray Analysis in breast cancer to Tailor Adjuvant Drugs Or Regimens, a randomized phase III study.Primary operable breast cancerNL-OMON23149etherlands Cancer Institute-Antoni van Leeuwenhoek Hospital660
已完成
不适用
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung CancerLung CancerNCT00340847National Cancer Institute (NCI)500